Bibliografía científicaBibliografía científica

En esta sección encontrará una selección de las publicaciones científicas sobre los Trastornos del Movimiento para los 11 diferentes tipos establecidos por la International Parkinson & Movement Disorder Society. Se han seleccionado sólo aquellas publicaciones que presenten el término de búsqueda en el título (inglés).

Los artículos presentados incluyen aquellos publicados desde enero de 2010. El listado de publicaciones de actualizará mensualmente. Si lo desea, puede recibir una alerta de la actualización por correo electrónico. Para ello ha de registrarse.

Búsqueda
Enfermedad de Parkinson y Parkinsonismo Parkinson’s disease & Parkinsonism 2329 artículos Viendo del 1 al 40 de 2329 artículos
Pub MED

Serum sodium and chloride are inversely associated with dyskinesia in Parkinson's disease patients.NUEVO

Mao CJ, Zhong CK, Yang Y, Yang YP, Wang F, Chen J, Zhang JR, Zhang HJ, Jin H, Xu LL, Huang JY, Liu CF.
Brain Behav. 2017 Nov 9;7(12):e00867. doi: 10.1002/brb3.867. eCollection 2017 Dec.
Pub MED

Analysis of free-living gait in older adults with and without Parkinson's disease and with and without a history of falls: identifying generic and disease specific characteristics.NUEVO

Del Din S, Galna B, Godfrey A, Bekkers EM, Pelosin E, Nieuwhof F, Mirelman A, Hausdorff JM, Rochester L.
J Gerontol A Biol Sci Med Sci. 2017 Dec 30. doi: 10.1093/gerona/glx254. [Epub ahead of print]
Pub MED

Pramipexole dihydrochloride loaded chitosan nanoparticles for nose to brain delivery: Development, characterization and in vivo anti-Parkinson activity.NUEVO

Raj R, Wairkar S, Sridhar V, Gaud R.
Int J Biol Macromol. 2017 Dec 13;109:27-35. doi: 10.1016/j.ijbiomac.2017.12.056. [Epub ahead of print]
Pub MED

Successful ablation of a right atrium-axillary ventricular accessory pathway associated with Wolff-Parkinson-White syndrome.NUEVO

Yuan Y, Long D, Dong J, Tao L, Ma C.
Pacing Clin Electrophysiol. 2017 Dec;40(12):1489-1491. doi: 10.1111/pace.13114. Epub 2017 Aug 26.
Pub MED

Parkinson revealed by a shadow at sunset.NUEVO

Di Gennaro G, Scoppetta C.
Eur Rev Med Pharmacol Sci. 2017 Dec;21(23):5297. doi: 10.26355/eurrev_201712_13948. No abstract available.
Pub MED

The analysis of relationship between selected sociodemografic factors and disorders of speech organs in Parkinson`s patients.NUEVO

Pawlukowska W, Skonieczna-Żydecka K, Rotter I, Honczarenko K, Nowacki P.
BMC Neurol. 2017 Dec 21;17(1):221. doi: 10.1186/s12883-017-1003-2.
Pub MED

Using Medical Claims Analyses to Understand Interventions for Parkinson Patients.NUEVO

Bloem BR, Ypinga JHL, Willis A, Canning CG, Barker RA, Munneke M, De Vries NM.
J Parkinsons Dis. 2017 Dec 6. doi: 10.3233/JPD-171277. [Epub ahead of print]
Pub MED

Adenosine-sensitive Wolff-Parkinson-White: Longer time across the atrioventricular groove.NUEVO

Beach C, Follansbee CW, Beerman L, Mazzocco S, Wang L, Arora G.
Pacing Clin Electrophysiol. 2017 Dec 9. doi: 10.1111/pace.13257. [Epub ahead of print]
Pub MED

Sex disparities in health and health care utilization after Parkinson diagnosis: Rethinking PD associated disability.NUEVO

Fullard ME, Thibault DP, Todaro V, Foster S, Katz L, Morgan R, Kern DS, Schwalb JM, Urrea Mendoza E, Dahodwala N, Shulman L, Willis AW.
Parkinsonism Relat Disord. 2017 Dec 14. pii: S1353-8020(17)30838-6. doi: 10.1016/j.parkreldis.2017.12.012. [Epub ahead of print]
Pub MED

[Safinamide from daily clinical practice: first clinical steps].

Pagonabarraga J, Kulisevsky J.
Rev Neurol. 2017 Nov 16;65(10):433-438. Spanish.
Pub MED

Role of magnetic resonance planimetry and magnetic resonance parkinsonism index in discriminating Parkinson's disease and progressive supranuclear palsy: a retrospective study based on 1.5 and 3 T MRI.

Nizamani WM, Mubarak F, Barakzai MD, Ahmed MS.
Int J Gen Med. 2017 Oct 31;10:375-384. doi: 10.2147/IJGM.S134297. eCollection 2017.
Pub MED

Impairment of non-associative learning in a rat experimental model of preclinical stage of Parkinson's disease.

Abdurasulova IN, Ekimova IV, Matsulevich AV, Gazizova AR, Klimenko VM, Pastukhov YF.
Dokl Biol Sci. 2017 Sep;476(1):188-190. doi: 10.1134/S0012496617050039. Epub 2017 Nov 4.
Pub MED

Computational systems biology approaches for Parkinson's disease.

Glaab E.
Cell Tissue Res. 2017 Nov 29. doi: 10.1007/s00441-017-2734-5. [Epub ahead of print] Review.
Pub MED

South African guideline on deep brain stimulation for Parkinson's disease.

Anderson DG, Van Coller R, Carr J.
S Afr Med J. 2017 Nov 6;107(10):1027-1032.
Pub MED

Oxidative stress and cellular pathologies in Parkinson's disease.

Puspita L, Chung SY, Shim JW.
Mol Brain. 2017 Nov 28;10(1):53. doi: 10.1186/s13041-017-0340-9. Review.
Pub MED

Prospective memory functioning in individuals with Parkinson's disease: a systematic review.

Costa A, Caltagirone C, Carlesimo GA.
Clin Neuropsychol. 2017 Nov 28:1-23. doi: 10.1080/13854046.2017.1407457. [Epub ahead of print]
Pub MED

Sleep disorder and altered locomotor activity as biomarkers of the Parkinson's disease cholinopathy in rat.

Ciric J, Lazic K, Kapor S, Perovic M, Petrovic J, Pesic V, Kanazir S, Saponjic J.
Behav Brain Res. 2017 Nov 21;339:79-92. doi: 10.1016/j.bbr.2017.11.021. [Epub ahead of print]
Pub MED

S-Nitrosylation of PINK1 Attenuates PINK1/Parkin-Dependent Mitophagy in hiPSC-Based Parkinson's Disease Models.

Oh CK, Sultan A, Platzer J, Dolatabadi N, Soldner F, McClatchy DB, Diedrich JK, Yates JR 3rd, Ambasudhan R, Nakamura T, Jaenisch R, Lipton SA.
Cell Rep. 2017 Nov 21;21(8):2171-2182. doi: 10.1016/j.celrep.2017.10.068.
Pub MED

Mutation Analysis of Consanguineous Moroccan Patients with Parkinson's Disease Combining Microarray and Gene Panel.

Bouhouche A, Tesson C, Regragui W, Rahmani M, Drouet V, Tibar H, Souirti Z, Ben El Haj R, Bouslam N, Yahyaoui M, Brice A, Benomar A, Lesage S.
Front Neurol. 2017 Oct 31;8:567. doi: 10.3389/fneur.2017.00567. eCollection 2017.
Pub MED

GYY4137, an H(2)S Slow-Releasing Donor, Prevents Nitrative Stress and α-Synuclein Nitration in an MPTP Mouse Model of Parkinson's Disease.

Hou X, Yuan Y, Sheng Y, Yuan B, Wang Y, Zheng J, Liu CF, Zhang X, Hu LF.
Front Pharmacol. 2017 Oct 30;8:741. doi: 10.3389/fphar.2017.00741. eCollection 2017.
Pub MED

Impact of inability to turn in bed assessed by a wearable three-axis accelerometer on patients with Parkinson's disease.

Uchino K, Shiraishi M, Tanaka K, Akamatsu M, Hasegawa Y.
PLoS One. 2017 Nov 9;12(11):e0187616. doi: 10.1371/journal.pone.0187616. eCollection 2017.
Pub MED

cJun N-terminal kinase (JNK) mediates cortico-striatal signaling in a model of Parkinson's disease.

Spigolon G, Cavaccini A, Trusel M, Tonini R, Fisone G.
Neurobiol Dis. 2017 Oct 28;110:37-46. doi: 10.1016/j.nbd.2017.10.015. [Epub ahead of print]
Pub MED

Can there be learning potential in Parkinson's disease? A comparison with healthy older adults.

Sales A, Pitarque A, Escudero J, Satorres E, Meléndez JC.
Dev Neuropsychol. 2017 Oct 31:1-10. doi: 10.1080/87565641.2017.1391265. [Epub ahead of print]
Pub MED

Sleep fragmentation and Parkinson's disease pathology in older adults without Parkinson's disease.

Sohail S, Yu L, Schneider JA, Bennett DA, Buchman AS, Lim ASP.
Mov Disord. 2017 Oct 30. doi: 10.1002/mds.27200. [Epub ahead of print]
Pub MED

(11) C-PE2I and (18) F-Dopa PET for assessing progression rate in Parkinson's: A longitudinal study.

Li W, Lao-Kaim NP, Roussakis AA, Martín-Bastida A, Valle-Guzman N, Paul G, Loane C, Widner H, Politis M, Foltynie T, Barker RA, Piccini P.
Mov Disord. 2017 Oct 30. doi: 10.1002/mds.27183. [Epub ahead of print]
Pub MED

Combining olfactory test and motion analysis sensors in Parkinson's disease preclinical diagnosis: a pilot study.

Maremmani C, Cavallo F, Purcaro C, Rossi G, Salvadori S, Rovini E, Esposito D, Pieroni A, Ramat S, Vanni P, Fattori B, Meco G.
Acta Neurol Scand. 2017 Oct 29. doi: 10.1111/ane.12862. [Epub ahead of print]
Pub MED

The changing landscape of surgery for Parkinson's Disease.

Lozano CS, Tam J, Lozano AM.
Mov Disord. 2017 Nov 30. doi: 10.1002/mds.27228. [Epub ahead of print] Review.
Pub MED

Association of circulating manganese levels with Parkinson's disease: A meta-analysis.

Du K, Liu MY, Pan YZ, Zhong X, Wei MJ.
Neurosci Lett. 2017 Nov 28;665:92-98. doi: 10.1016/j.neulet.2017.11.054. [Epub ahead of print]
Pub MED

Association between rs823128 polymorphism and the risk of Parkinson's disease: A meta-analysis.

Cai M, Liu Z, Li W, Wang Y, Xie AM.
Neurosci Lett. 2017 Nov 27. pii: S0304-3940(17)30966-7. doi: 10.1016/j.neulet.2017.11.057. [Epub ahead of print]
Pub MED

Dopamine receptors and BDNF-haplotypes predict dyskinesia in Parkinson's disease.

Kusters CDJ, Paul KC, Guella I, Bronstein JM, Sinsheimer JS, Farrer MJ, Ritz BR.
Parkinsonism Relat Disord. 2017 Nov 24. pii: S1353-8020(17)30805-2. doi: 10.1016/j.parkreldis.2017.11.339. [Epub ahead of print]
Pub MED

Raphe pallidus is not important to central chemoreception in a rat model of Parkinson's disease.

Oliveira LM, Moreira TS, Takakura AC.
Neuroscience. 2017 Nov 27. pii: S0306-4522(17)30841-2. doi: 10.1016/j.neuroscience.2017.11.038. [Epub ahead of print]
Pub MED

Alpha-synuclein, proteotoxicity and Parkinson's disease: Search for neuroprotective therapy.

Ganguly U, Chakrabarti SS, Kaur U, Mukherjee A, Chakrabarti S.
Curr Neuropharmacol. 2017 Nov 28. doi: 10.2174/1570159X15666171129100944. [Epub ahead of print]
Pub MED

The Design and Evaluation of an l-Dopa-Lazabemide Prodrug for the Treatment of Parkinson's Disease.

Hoon M, Petzer JP, Viljoen F, Petzer A.
Molecules. 2017 Nov 27;22(12). pii: E2076. doi: 10.3390/molecules22122076.
Pub MED

[Screening of executive functions in patients with Parkinson's disease using the new rapid test PAL-5].

Scheffels JF, Engels JE, Kalbe E, Kessler J.
Fortschr Neurol Psychiatr. 2017 Nov 29. doi: 10.1055/s-0043-122390. [Epub ahead of print] German.
Pub MED

Critical Roles of Glutaredoxin in Brain Cells - Implications for Parkinson's Disease.

Gorelenkova Miller O, Mieyal JJ.
Antioxid Redox Signal. 2017 Nov 28. doi: 10.1089/ars.2017.7411. [Epub ahead of print]
Pub MED

Activation of the mitochondrial unfolded protein response promotes longevity and dopamine neuron survival in Parkinson's disease models.

Cooper JF, Machiela E, Dues DJ, Spielbauer KK, Senchuk MM, Van Raamsdonk JM.
Sci Rep. 2017 Nov 27;7(1):16441. doi: 10.1038/s41598-017-16637-2.
Pub MED

Alpha-Synuclein transgenic mice, h-α-SynL62, display α-Syn aggregation and a dopaminergic phenotype reminiscent of Parkinson's disease.

Frahm S, Melis V, Horsley D, Rickard JE, Riedel G, Fadda P, Scherma M, Harrington CR, Wischik CM, Theuring F, Schwab K.
Behav Brain Res. 2017 Nov 24;339:153-168. doi: 10.1016/j.bbr.2017.11.025. [Epub ahead of print]
Pub MED

The Dominant-Subthalamic Nucleus Phenomenon in Bilateral Deep Brain Stimulation for Parkinson's Disease: Evidence from a Gait Analysis Study.

Rizzone MG, Ferrarin M, Lanotte MM, Lopiano L, Carpinella I.
Front Neurol. 2017 Oct 30;8:575. doi: 10.3389/fneur.2017.00575. eCollection 2017.
Pub MED

Parkinson's Disease Severity at 3 Years Can Be Predicted from Non-Motor Symptoms at Baseline.

Ayala A, Triviño-Juárez JM, Forjaz MJ, Rodríguez-Blázquez C, Rojo-Abuin JM, Martínez-Martín P.
Front Neurol. 2017 Oct 30;8:551. doi: 10.3389/fneur.2017.00551. eCollection 2017.
Pub MED

Sex differences in LRRK2 G2019S and idiopathic Parkinson's Disease.

San Luciano M, Wang C, Ortega RA, Giladi N, Marder K, Bressman S, Saunders-Pullman R; Michael J Fox Foundation LRRK2 Consortium..
Ann Clin Transl Neurol. 2017 Oct 19;4(11):801-810. doi: 10.1002/acn3.489. eCollection 2017 Nov.
Viendo del 1 al 40 de 2329 artículos
Con el aval de:

Sociedad Española de Neurología

Sociedad Española
de Neurología
En colaboración con:

Zambon

Haga click en el logo para acceder
a información acerca de Zambon
NeuroAcademy
Utilizamos cookies propias y de terceros para identificar la sesión del usuario y mejorar nuestros servicios mediante el análisis de sus hábitos de navegación. Si continúa navegando por el sitio web manifiesta consentir su instalación y uso conforme lo anterior. Puede cambiar la configuración y obtener más información aquí.